JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB7159

Rabbit Anti-Human IgG H&L (Biotin) preadsorbed

Rabbit Anti-Human IgG H&L (Biotin) preadsorbed

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Anti-Human IgG H&L (Biotin)(ab7159) is a biotin conjugated secondary antibody that is suitable for Western blot, IHC and ELISA.

- Preadsorbed to minimize non-specific binding and high background staining
- Suitable for avidin-biotin complex (ABC) method or labeled streptavidin-biotin (LSAB) method

別名を表示する

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

Key facts

宿主種

Rabbit

ターゲット種

Human

ターゲットアイソタイプ

IgG

ターゲット特異性

Heavy & Light chains

最小限の交差反応性

Mouse,

血清吸着処理済み

Yes

標識

Biotin

励起波長/蛍光波長
アプリケーション

ELISA, WB, IM, ICC/IF, Dot, IHC-P

applications

クローン性

Polyclonal

特異性

No reaction was observed against Mouse Serum Proteins.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/20000 - 1/100000", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/5000", "notes":"<p></p>" }, "IM": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/2000 - 1/10000", "notes":"<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification
精製に関する特記事項
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.
バッファー組成
Preservative: 0.01% Sodium azide Constituents: 1% BSA, 0.88% Sodium chloride, 0.424% Potassium phosphate solution
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

製品プロトコール

ターゲットの情報

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

追加のターゲット

IGHG4,IGHG2,IGHG3

文献 (7)

Recent publications for all applications. Explore the full list and refine your search

Translational psychiatry 7:e1192 PubMed28786974

2017

Brain antibodies in the cortex and blood of people with schizophrenia and controls.

Applications

IHC-P

Species

Human

L J Glass,D Sinclair,D Boerrigter,K Naude,S J Fung,D Brown,V S Catts,P Tooney,M O'Donnell,R Lenroot,C Galletly,D Liu,T W Weickert,C Shannon Weickert

BMC pregnancy and childbirth 13:201 PubMed24191889

2013

Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization.

Applications

ELISA

Species

Unspecified reactive species

Oskar Hammar,Bodil Roth,Mariette Bengtsson,Thomas Mandl,Bodil Ohlsson

BMC research notes 6:329 PubMed23958111

2013

Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy.

Applications

Unspecified application

Species

Unspecified reactive species

Kerstin Berntorp,Anders Frid,Ragnar Alm,Gunilla Nordin Fredrikson,Klas Sjöberg,Bodil Ohlsson

Drug target insights 7:1-8 PubMed23400339

2013

Antibodies against gonadotropin-releasing hormone in patients with posterior laryngitis.

Applications

Unspecified application

Species

Unspecified reactive species

Hillevi Pendleton,Ragnar Alm,Gunilla Nordin Fredrikson,Bodil Ohlsson

Scandinavian journal of gastroenterology 48:27-34 PubMed23148737

2012

Gastrointestinal symptoms and psychological well-being in patients with microscopic colitis.

Applications

Unspecified application

Species

Unspecified reactive species

Bodil Roth,Bodil Ohlsson

Scandinavian journal of gastroenterology 47:1165-73 PubMed22835010

2012

Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility.

Applications

Unspecified application

Species

Unspecified reactive species

Oskar Hammar,Bodil Ohlsson,Béla Veress,Ragnar Alm,Gunilla Nordin Fredrikson,Agneta Montgomery

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 23:1000-6, e459 PubMed21714833

2011

Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum.

Applications

Unspecified application

Species

Unspecified reactive species

B Ohlsson,K Sjöberg,R Alm,G N Fredrikson
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com